Cancer and Leukemia Group B
Cancer and Leukemia Group B (CALGB)
Cancer and Leukemia Group B (pronounced: kan-ser and loo-kee-mee-uh groop bee), often abbreviated as CALGB, is a national clinical research group sponsored by the National Cancer Institute (NCI). It is dedicated to improving the understanding, prevention, and treatment of cancer and related diseases.
Etymology
The term "Cancer and Leukemia Group B" is derived from the diseases it primarily focuses on - Cancer and Leukemia. The "Group B" signifies its distinct identity among other similar research groups.
History
Cancer and Leukemia Group B was established in 1955 as one of the first clinical research groups in the United States. It was initially funded by the National Institutes of Health (NIH) and later by the National Cancer Institute.
Research Focus
CALGB conducts comprehensive research on various types of cancer and leukemia, including but not limited to Breast Cancer, Lung Cancer, Prostate Cancer, Colon Cancer, and different forms of leukemia such as Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), and Chronic Myeloid Leukemia (CML).
Related Terms
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Hematology: The branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood.
- Chemotherapy: A type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen.
- Radiation Therapy: Therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells.
External links
- Medical encyclopedia article on Cancer and Leukemia Group B
- Wikipedia's article - Cancer and Leukemia Group B
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski